Skip to main content
Retour
Watch Compare

ACTUATE THERAPEUTICS, INC.

Qualité des données : 83%
ACTU
Nasdaq Manufacturing Chemicals
1,86 €
▼ 0,07 € (-3,39%)
Cap. Boursière: 43,99 M
Prix
1,86 €
Cap. Boursière
43,99 M
Fourchette du Jour
1,77 € — 1,94 €
Fourchette 52 Semaines
1,77 € — 11,99 €
Volume
77 585
Ouverture 1,94 €
Moyenne 50J / 200J
3,55 €
47,73% below
Moyenne 50J / 200J
6,08 €
69,50% below

Quick Summary

Points Clés

Negative free cash flow of -19,21 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-536,74%
En dessous de la moyenne du secteur (-53,41%)
ROIC-390,17%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio2,74
Interest Coverage-1110,88

Valorisation

PE (TTM)
-1,98
En dessous de la moyenne du secteur (-1,48)
P/B Ratio4,02
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -2,0 -1,5
P/B 4,0 1,6
ROE % -536,7 -53,4
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -22,23 M
ROE -536,74% ROA -180,11%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -19,21 M
ROIC -390,17% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 2,74
Interest Coverage -1110,88 Asset Turnover N/A
Working Capital 11,07 M Tangible Book Value 10,94 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1,98 Forward P/E N/A
P/B Ratio 4,02 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -43,67%
Market Cap 43,99 M Enterprise Value 27,06 M
Per Share
EPS (Diluted TTM) -1,06 Revenue / Share N/A
FCF / Share -0,81 OCF / Share -0,81
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 86,41%
SBC-Adj. FCF -23,95 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024
Revenue — —
Net Income -22,23 M -27,29 M
EPS (Diluted) -1,06 -3,26
Gross Profit — —
Operating Income -22,50 M -25,16 M
EBITDA — —
R&D Expenses 10,29 M 18,68 M
SG&A Expenses — —
D&A — —
Interest Expense 20 250,0 18 717,0
Income Tax 800,0 800,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024
Total Assets 14,04 M 9,32 M
Total Liabilities 6,11 M 9,21 M
Shareholders' Equity 7,92 M 104 186,0
Total Debt — —
Cash & Equivalents 13,16 M 8,64 M
Current Assets 13,64 M 9,21 M
Current Liabilities 5,71 M 8,80 M